Acute ischemic stroke incidence after influenza or coronavirus disease 2019 among older US adults: A cross-sectional study using electronic health records
March 2026Journal of International Medical Research
BNT162b2 XBB.1.5-Adapted Single Dose Vaccine Uptake and Effectiveness in Children Aged 5-17 Years Using Linked Claims and Vaccine Registries in California and Louisiana
Sodium Zirconium Cyclosilicate Duration and Hyperkalemia-Related Healthcare Encounters in Patients with Heart Failure and Cardio/Renal Dysfunction: The GALVANIZE Outcome Study
October 2025Drugs - Real World OutcomesInfectious Diseases
Lipid-Lowering Therapy Patterns of High-Risk Cardiovascular Patients without Prior Myocardial Infarction or Stroke—VESALIUS-REAL—Results from Patients with High-Risk Diabetes in the U.S.
Subsequent treatments and outcomes in bacillus Calmette-Guerin–unresponsive patients with high-risk non-muscle invasive bladder cancer with carcinoma in situ: A real-world data analysis
Real-World Characteristics and Treatment History of Patients with Paroxysmal Nocturnal Hemoglobinuria Initiating Iptacopan in US Administrative Claims Data
MDS-536 Clinical Characteristics and Outcomes in Complement-Inhibitor–Treated Patients With Paroxysmal Nocturnal Hemoglobinuria in the United States: A Retrospective Claims Database Analysis
Sexually Transmitted Infection/Human Immunodeficiency Virus (STI/HIV) Testing, STIs, and HIV Pre-exposure Prophylaxis Use Among Men Who Have Sex With Men and Men Who Have Sex With Men and Women in the United States, 2019–2022
June 2024Clinical Infectious DiseasesINFECTIOUS DISEASE
Treatment patterns with intravesical bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder cancer (NMIBC): A real-world data analysis
Treatment patterns of patients with complement 3 glomerulopathy (C3G): a retrospective linked electronic medical record (EMR) and claims analysis #2066
May 2024Nephrology Dialysis TransplantationRARE DISEASE
A Retrospective Cohort Study of Recent Large Multiple Commercial Payer Databases to Elucidate Migraine-Specific Costs of Care by Specific Treatment Groups
A Retrospective Cohort Study of Recent Large Multiple Commercial Payer Databases to Elucidate Migraine-specific Health Care Resource Utilization (HCRU), and Migraine-specific Costs of Care
Detailed Analysis of Current Migraine Treatment Trends by Treatment Groups in a Large Retrospective Cohort Study of Recent Large Multiple Commercial Payer Databases
BNT162b2 XBB.1.5-Adapted Single Dose Vaccine Uptake and Effectiveness in Children Aged 5-17 Years Using Linked Claims and Vaccine Registries in California and Louisiana
2024–2025 BNT162b2 COVID-19 vaccine effectiveness in non-immunocompromised adults: mid-season estimates from vaccine registries in two states linked to administrative claims
Real-World Effectiveness of a Third Dose of mRNA-1273 versus BNT162b2 on Inpatient and Medically Attended COVID-19 among Immunocompromised Adults in the United States
Use of Paxlovid for Treatment of Acute COVID-19 and Occurrence of Post-COVID Conditions among Children and Adults at High-Risk for Severe COVID-19, April 1 – December 31, 2022
November 27 2023Open Forum Infectious DiseasesCOVID-19
Incidence Rates for an Extensive List of Adverse Events of Special Interest in the Pre-COVID-19 and Active COVID-19 Eras: A Comprehensive Source for Representative Historical Background Rates in the US General Population
Signal detection, refinement, & evaluation of cerebral venous sinus thrombosis following Spikevax administration in a US active surveillance… (Abstract #1252)
Methodological development of an enhanced safety surveillance for the Janssen COVID-19 vaccine (JCOVDEN) through rapid cycle analysis of US administrative claims data (Abstract #1291)
Active surveillance and evaluation of anosmia/ageusia following mRNA-1273 administration: Learnings from a US administrative claims database study (Abstract #1076)
Appropriate washout period for adverse events of special interest (AESI) in vaccine active surveillance utilizing an administrative claims database (Abstract #790)
Clinical characteristics and healthcare resource utilization among patients identified with post-acute sequelae of COVID-19 (long-COVID) in US administrative claims data (Abstract #426)
Concordance between analyses from the moderna global safety database (GSD) and a US population-based study for COVID-19 vaccine, mRNA-1273 (Abstract #78)
Continuity of care among patients newly initiated on second-generation oral or long-acting injectable antipsychotics during a schizophrenia-related inpatient stay
A Descriptive Cohort Study of Drug Utilization Patterns Among Patients Hospitalized With Coronavirus Disease 2019 in the United States, January 2021–February 2022
Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I Study
Analytics/RWE, Clinical Trial
Evidation measures health in everyday life and enables anyone to participate in ground-breaking studies, health programs and research. Built upon a foundation of user privacy and control over permissioned...
Read more
Clinical Trial
Fortrea and HealthVerity collaborate to unlock the power of real-world data for clinical research. By pairing Fortrea’s clinical trial execution expertise with HealthVerity’s vast data ecosystem and patient identity...
Read more
Clinical Trial
ICON plc is a leading global provider of outsourced development and commercialization services to the pharmaceutical, biotechnology, and medical device industries. With operations in over 50 countries...
Read more
Analytics/RWE, Clinical Trial
Medidata is leading the digital transformation of life sciences, creating hope for millions of patients worldwide. Medidata generates the evidence and insights needed to help pharmaceutical, biotech, medical device and diagnostics...
Read more
Clinical Trial
Parexel is a leading global clinical research organization (CRO) providing comprehensive solutions to accelerate the development and delivery of innovative therapies. With deep expertise across therapeutic areas...
Read more
Analytics/RWE, Clinical Trial, Lab, Government
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world’s largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease...
Read more
Clinical Trial
Slipstream IT specializes in providing advanced IT infrastructure, cloud solutions, and technology services to organizations in highly regulated industries. With a focus on reliability, scalability, and...
Read more
Analytics/RWE, Clinical Trial, Government
Syneos Health® is the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer performance to address modern market realities. We bring together...
Read more
Clinical Trial
Verily, an Alphabet company, is dedicated to using data-driven insights to improve human health. Combining expertise in technology, data science, and life sciences, Verily develops tools and platforms that advance...
Read more
Impact on hospitalizations of long-term versus short-term therapy with sodium zirconium cyclosilicate during routine outpatient care of patients with hyperkalemia: the recognize I study
Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases
November 13, 2022Rheumatology and TherapyImmunology
Real-world comparative effectiveness of mRNA-1273 and BNT162b2 vaccines among immunocompromised adults identified in administrative claims data in the United States
The impact of data truncation on rates of vaccine-associated adverse events utilizing open and closed claims: Lessons from post-marketing safety surveillance of the SARS-COV-2 MRNA-1273 vaccine (Abstract #186)
Durability of the Single-Dose Ad26.COV2.S Vaccine in the Prevention of COVID-19 Infections and Hospitalizations in the US Before and During the Delta Variant Surge
Comparison of Healthcare Resource Utilization Between Patients Who Engaged or Did Not Engage With a Prescription Digital Therapeutic for Opioid Use Disorder
October 29, 2021Clinicoecon Outcomes ResDigital Therapeutics
Clinical Burden and Practice Patterns in Patients With Chronic Hypoparathyroidism in the United States (US): A Claims Data Analysis Using Diagnosis-Based Criteria
COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients
Real-world reduction in healthcare resource utilization following treatment of opioid use disorder with reSET-O, a novel prescription digital therapeutic
November 4, 2020Pharmacoecon OutcomesDigital Therapeutics
Renin-Angiotensin-Aldosterone-System inhibitor use in patients with COVID-19 infection and prevention of serious events: a cohort study in commercially insured patients in the US
Using Clinical Data Standards to Facilitate Comparisons of Acute Myeloid Leukemia Treatment Patterns and Outcomes in Real-World Clinical Care and Pooled Clinical Trial Populations
